Position in ALNY
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$22,379,054
+$4,119,364 QoQ
Shares Held
67,637
+47.3% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 32.16434791608144.ToString("F0")%
Shared 0.ToString("F0")%
None 67.83565208391856.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $464,981,245 across 201 Biotechnology names. ALNY ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268,062 | $119,700,405 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63,987 | $49,438,915 | |
| 3 | INSM |
INSMED Inc
|
138,281 | $22,611,709 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
67,637 | $22,379,054 | |
| 5 | EXEL |
Exelixis, Inc.
|
399,612 | $17,139,358 | |
| 6 | ARGX |
Argenx SE
|
23,247 | $16,976,121 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
194,304 | $12,557,867 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
378,656 | $10,488,771 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,379,054 | 67,637 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $18,259,690 | 45,919 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $22,106,880 | 48,480 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,893,244 | 30,339 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,583,743 | 20,679 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,370,177 | 18,572 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,172,214 | 18,806 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $4,528,548 | 18,636 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,536,764 | 16,974 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,200,566 | 16,721 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,792,867 | 15,770 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,825,357 | 14,875 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,946,707 | 14,710 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,276,005 | 13,785 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,649,718 | 13,238 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,718,550 | 11,783 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,711,920 | 16,608 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,695,304 | 15,894 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,473,788 | 13,102 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,736,562 | 10,244 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,284,970 | 9,101 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $725,492 | 5,582 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $827,008 | 5,680 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $787,945 | 5,320 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $516,275 | 4,743 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||